Skip to main navigation Skip to search Skip to main content

A Phase II, Multicenter, Double Blinded, Randomized, Placebo Controlled, Parallel-Group, Single-Dose Study to Determine the Safety, Preliminary Efficacy, and Pharmacokinetics of ARG-007 in Acute Ischemic Stroke Patients

Project: Research

Project Details

StatusActive
Effective start/end date25/06/24 → 24/06/29

Clinical Trial Phase

  • Phase II